Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Birinapant |
| Trade Name | |
| Synonyms | TL32711 |
| Drug Descriptions |
TL32711 (birinapant) is a a bivalent SMAC-mimetic compound, which binds to and inhibits Inhibitor of Apoptosis proteins (IAPs), leading to tumor cell death (PMID: 24563541, PMID: 26566079). |
| DrugClasses | SMAC Mimetic 8 |
| CAS Registry Number | 1260251-31-7 |
| NCIT ID | C88295 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Birinapant | Birinapant | 1 | 2 |
| Birinapant + Fulvestrant | Birinapant Fulvestrant | 0 | 0 |
| Birinapant + Pembrolizumab | Birinapant Pembrolizumab | 0 | 1 |
| Birinapant + Radiotherapy | Birinapant Radiotherapy | 0 | 0 |